Walker BD - Search Results

1

Unravelling the mechanisms of durable control of HIV-1.

Walker BD, Yu XG. Walker BD, et al. Nat Rev Immunol. 2013 Jul;13(7):487-98. doi: 10.1038/nri3478. Nat Rev Immunol. 2013. PMID: 23797064 Review.

2

Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.

Harrer T, Harrer E, Kalams SA, Barbosa P, Trocha A, Johnson RP, Elbeik T, Feinberg MB, Buchbinder SP, Walker BD. Harrer T, et al. Among authors: walker bd. J Immunol. 1996 Apr 1;156(7):2616-23. J Immunol. 1996. PMID: 8786327

3

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.

Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, Walker BD. Rosenberg ES, et al. Among authors: walker bd. Science. 1997 Nov 21;278(5342):1447-50. doi: 10.1126/science.278.5342.1447. Science. 1997. PMID: 9367954

4

HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.

Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. Collins KL, et al. Among authors: walker bd. Nature. 1998 Jan 22;391(6665):397-401. doi: 10.1038/34929. Nature. 1998. PMID: 9450757

5

Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans.

Wagner L, Yang OO, Garcia-Zepeda EA, Ge Y, Kalams SA, Walker BD, Pasternack MS, Luster AD. Wagner L, et al. Among authors: walker bd. Nature. 1998 Feb 26;391(6670):908-11. doi: 10.1038/36129. Nature. 1998. PMID: 9495345

6

Immune control of HIV-1 replication.

Walker BD, Rosenberg ES, Hay CM, Basgoz N, Yang OO. Walker BD, et al. Adv Exp Med Biol. 1998;452:159-67. doi: 10.1007/978-1-4615-5355-7_17. Adv Exp Med Biol. 1998. PMID: 9889969 Review. No abstract available.

7

Characterization of HIV-1-specific T-helper cells in acute and chronic infection.

Rosenberg ES, LaRosa L, Flynn T, Robbins G, Walker BD. Rosenberg ES, et al. Among authors: walker bd. Immunol Lett. 1999 Mar;66(1-3):89-93. doi: 10.1016/s0165-2478(98)00165-5. Immunol Lett. 1999. PMID: 10203039

8

T lymphocyte responses in HIV-1 infection: implications for vaccine development.

Brander C, Walker BD. Brander C, et al. Among authors: walker bd. Curr Opin Immunol. 1999 Aug;11(4):451-9. doi: 10.1016/S0952-7915(99)80076-4. Curr Opin Immunol. 1999. PMID: 10448136 Review.

9

Immune control of HIV-1 after early treatment of acute infection.

Rosenberg ES, Altfeld M, Poon SH, Phillips MN, Wilkes BM, Eldridge RL, Robbins GK, D'Aquila RT, Goulder PJ, Walker BD. Rosenberg ES, et al. Among authors: walker bd. Nature. 2000 Sep 28;407(6803):523-6. doi: 10.1038/35035103. Nature. 2000. PMID: 11029005 Clinical Trial.

10

Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection.

Altfeld M, Rosenberg ES, Shankarappa R, Mukherjee JS, Hecht FM, Eldridge RL, Addo MM, Poon SH, Phillips MN, Robbins GK, Sax PE, Boswell S, Kahn JO, Brander C, Goulder PJ, Levy JA, Mullins JI, Walker BD. Altfeld M, et al. Among authors: walker bd. J Exp Med. 2001 Jan 15;193(2):169-80. doi: 10.1084/jem.193.2.169. J Exp Med. 2001. PMID: 11148221 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

669 results

Search Page